Coronavirus Update - 14th October 2020

Despite the recent rises in Covid-19 cases throughout the UK and Europe, Arcinova remains open for business at full capacity as we have done throughout this pandemic. As the situation continues to evolve, we will keep all our customers and stakeholders informed of our activities through this web-page which is updated on a regular basis.

We would like to take this opportunity to thank our clients and staff for their continued support over this period of restricted movement. 

We fully comply with all government guidance on minimising the risks of COVID-19 and have published our risk assessment here

The Growing Popularity of Capsule Manufacturing in Pharma

Our Head of Drug Product and Scientific Direction, Steve Byard, recently shared his thoughts on the benefits of capsule manufacturing. In his article for PMPS, Steve explains the factors that must be considered when deciding between tablet and capsule dosage forms, along with the advantages that capsules offer over tablets in specific situations. The article also explores how capsule manufacturing can be employed to reduce the time to clinic by circumventing the need for extended stability studies. Read the article here


Discover how Arcinova can help

We provide a fully integrated approach to drug development, speak to our team and discover how we can help you fast forward to market.